Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Dimensions and modulators of behavioural and mental-health change during the Covid-19 pandemic

Adam Hampshire, Peter Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, Jon E. Grant, Samuel R. Chamberlain
doi: https://doi.org/10.1101/2020.06.18.20134635
Adam Hampshire
1Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.hampshire{at}imperial.ac.uk
Peter Hellyer
1Imperial College London
2King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eyal Soreq
1Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitul A. Mehta
2King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Ioannidis
3Cambridgeshire and Peterborough NHS Foundation Trust
4Department of Psychiatry, University of Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Trender
1Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon E. Grant
5Department of Psychiatry, University of Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel R. Chamberlain
3Cambridgeshire and Peterborough NHS Foundation Trust
4Department of Psychiatry, University of Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

How has the Covid-19 pandemic affected mental health? What are the most common positives and negatives? How do population variables mediate the impact on mood and behaviour? Who is most at risk of adverse consequences? Which pragmatic measures can help? We address these questions in a data-driven manner by applying multivariate, machine-learning and natural-language processing methods to a survey database collected from 376,987 members of the general public. We report that small average changes in mood from pre-to mid-pandemic obfuscate substantial consequences, both positive and negative, for people from particular sub-populations, vocations, circumstances and personality profiles. The coping strategies that people find helpful during the pandemic are correspondingly diverse yet predictable. We propose that by combining psychological, and demographic variables, it is possible to identify individuals who are at most risk of adverse consequences and to extract individually tailored advice from the collective lived experiences of the general population.

Competing Interest Statement

Disclosures: Dr. Chamberlain consults for Promentis, and receives stipends for journal editorial work from Elsevier. Dr. Grant has received research grants from the TLC Foundation for Body-Focused Repetitive Behaviors, Biohaven, Promentis, and Avanir Pharmaceuticals. Prof. Mehta has received grant income from Takeda Pharmaceuticals, Johnson & Johnson and Lundbeck.

Clinical Trial

This was a large scale observational study run in collaboration with BBC2 Horizon. It was not a clinical trial.

Funding Statement

Dr Hampshire is supported by the UK Dementia Research Institute and Biomedical Research Centre at Imperial College London with technology development supported by EU-CIG EC Marie‐Curie CIG and NIHR grant II-LB-0715-20006. Dr Soreq's role was supported by MRC grant MR/R005370/1. William Trender is supported by the EPSRC Center for Doctoral Training in Neurotechnology. Dr Chamberlain's role in this study was funded by a Wellcome Trust Clinical Fellowship (Reference 110049/Z/15/Z). Mitul Mehta is in part supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. We would like to acknowledge COST Action CA16207 'European Network for Problematic Usage of the Internet', supported by COST (European Cooperation in Science and Technology); and the support of the National UK Research Network for Behavioural Addictions (NUK-BA).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Imperial College Research Ethics Committee. 17IC4009 ICREC

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Extended analyses have been added in this revision.

Data Availability

Summary data for this cohort are provided in the supplementary appendices.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Dimensions and modulators of behavioural and mental-health change during the Covid-19 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dimensions and modulators of behavioural and mental-health change during the Covid-19 pandemic
Adam Hampshire, Peter Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, Jon E. Grant, Samuel R. Chamberlain
medRxiv 2020.06.18.20134635; doi: https://doi.org/10.1101/2020.06.18.20134635
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Dimensions and modulators of behavioural and mental-health change during the Covid-19 pandemic
Adam Hampshire, Peter Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, Jon E. Grant, Samuel R. Chamberlain
medRxiv 2020.06.18.20134635; doi: https://doi.org/10.1101/2020.06.18.20134635

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)